Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles

Joshua Owen, Conor McEwan, Heather Nesbitt, Phurit Bovornchutichai, Raymond Averre, Mark Borden, Anthony McHale, John F Callan, Eelanor Stride

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Hypoxia has been shown to be a key factor inhibiting the successful treatment of solid tumours. Existing strategies for reducing hypoxia, however, have shown limited efficacy and/or adverse side effects. The aim of this study was to investigate the potential for reducing tumour hypoxia using an orally delivered suspension of surfactant-stabilised oxygen nanobubbles. Experiments were carried out in a mouse xenograft tumour model for human pancreatic cancer (BxPc-3 cells in male SCID mice). A single dose of 100 μL of oxygen saturated water, oxygen nanobubbles or argon nanobubbles was administered via gavage. Animals were sacrificed 30 minutes post-treatment (3 per group) and expression of hypoxiainducible-factor-1α (HIF1α) protein measured by real time quantitative polymerase chain reaction and Western blot analysis of the excised tumour tissue. Neither the oxygen saturated water nor argon nanobubbles produced a statistically significant change in HIF1α expression at the transcriptional level. In contrast, a reduction of 75% and 25% in the transcriptional and translational expression of HIF1α respectively (p
LanguageEnglish
Pagese0168088
JournalPLoS ONE
Volume11
Issue number12
DOIs
Publication statusPublished - 30 Dec 2016

Fingerprint

Oral Administration
Oxygen
Argon
Neoplasms
SCID Mice
Water
Pancreatic Neoplasms
Heterografts
Surface-Active Agents
Real-Time Polymerase Chain Reaction
Suspensions
Western Blotting
Tumor Hypoxia
Therapeutics
Proteins
Hypoxia

Keywords

  • Nanobubbles
  • Oxygen
  • Hypoxia
  • HIF-1 alpha

Cite this

Owen, J., McEwan, C., Nesbitt, H., Bovornchutichai, P., Averre, R., Borden, M., ... Stride, E. (2016). Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles. PLoS ONE, 11(12), e0168088. https://doi.org/10.1371/journal.pone.0168088
Owen, Joshua ; McEwan, Conor ; Nesbitt, Heather ; Bovornchutichai, Phurit ; Averre, Raymond ; Borden, Mark ; McHale, Anthony ; Callan, John F ; Stride, Eelanor. / Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles. In: PLoS ONE. 2016 ; Vol. 11, No. 12. pp. e0168088.
@article{f351f41f27404c4aacf5c836b27260c8,
title = "Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles",
abstract = "Hypoxia has been shown to be a key factor inhibiting the successful treatment of solid tumours. Existing strategies for reducing hypoxia, however, have shown limited efficacy and/or adverse side effects. The aim of this study was to investigate the potential for reducing tumour hypoxia using an orally delivered suspension of surfactant-stabilised oxygen nanobubbles. Experiments were carried out in a mouse xenograft tumour model for human pancreatic cancer (BxPc-3 cells in male SCID mice). A single dose of 100 μL of oxygen saturated water, oxygen nanobubbles or argon nanobubbles was administered via gavage. Animals were sacrificed 30 minutes post-treatment (3 per group) and expression of hypoxiainducible-factor-1α (HIF1α) protein measured by real time quantitative polymerase chain reaction and Western blot analysis of the excised tumour tissue. Neither the oxygen saturated water nor argon nanobubbles produced a statistically significant change in HIF1α expression at the transcriptional level. In contrast, a reduction of 75{\%} and 25{\%} in the transcriptional and translational expression of HIF1α respectively (p",
keywords = "Nanobubbles, Oxygen, Hypoxia, HIF-1 alpha",
author = "Joshua Owen and Conor McEwan and Heather Nesbitt and Phurit Bovornchutichai and Raymond Averre and Mark Borden and Anthony McHale and Callan, {John F} and Eelanor Stride",
year = "2016",
month = "12",
day = "30",
doi = "10.1371/journal.pone.0168088",
language = "English",
volume = "11",
pages = "e0168088",
journal = "PLoS ONE",
issn = "1932-6203",
number = "12",

}

Owen, J, McEwan, C, Nesbitt, H, Bovornchutichai, P, Averre, R, Borden, M, McHale, A, Callan, JF & Stride, E 2016, 'Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles', PLoS ONE, vol. 11, no. 12, pp. e0168088. https://doi.org/10.1371/journal.pone.0168088

Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles. / Owen, Joshua; McEwan, Conor; Nesbitt, Heather; Bovornchutichai, Phurit; Averre, Raymond; Borden, Mark; McHale, Anthony; Callan, John F; Stride, Eelanor.

In: PLoS ONE, Vol. 11, No. 12, 30.12.2016, p. e0168088.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles

AU - Owen, Joshua

AU - McEwan, Conor

AU - Nesbitt, Heather

AU - Bovornchutichai, Phurit

AU - Averre, Raymond

AU - Borden, Mark

AU - McHale, Anthony

AU - Callan, John F

AU - Stride, Eelanor

PY - 2016/12/30

Y1 - 2016/12/30

N2 - Hypoxia has been shown to be a key factor inhibiting the successful treatment of solid tumours. Existing strategies for reducing hypoxia, however, have shown limited efficacy and/or adverse side effects. The aim of this study was to investigate the potential for reducing tumour hypoxia using an orally delivered suspension of surfactant-stabilised oxygen nanobubbles. Experiments were carried out in a mouse xenograft tumour model for human pancreatic cancer (BxPc-3 cells in male SCID mice). A single dose of 100 μL of oxygen saturated water, oxygen nanobubbles or argon nanobubbles was administered via gavage. Animals were sacrificed 30 minutes post-treatment (3 per group) and expression of hypoxiainducible-factor-1α (HIF1α) protein measured by real time quantitative polymerase chain reaction and Western blot analysis of the excised tumour tissue. Neither the oxygen saturated water nor argon nanobubbles produced a statistically significant change in HIF1α expression at the transcriptional level. In contrast, a reduction of 75% and 25% in the transcriptional and translational expression of HIF1α respectively (p

AB - Hypoxia has been shown to be a key factor inhibiting the successful treatment of solid tumours. Existing strategies for reducing hypoxia, however, have shown limited efficacy and/or adverse side effects. The aim of this study was to investigate the potential for reducing tumour hypoxia using an orally delivered suspension of surfactant-stabilised oxygen nanobubbles. Experiments were carried out in a mouse xenograft tumour model for human pancreatic cancer (BxPc-3 cells in male SCID mice). A single dose of 100 μL of oxygen saturated water, oxygen nanobubbles or argon nanobubbles was administered via gavage. Animals were sacrificed 30 minutes post-treatment (3 per group) and expression of hypoxiainducible-factor-1α (HIF1α) protein measured by real time quantitative polymerase chain reaction and Western blot analysis of the excised tumour tissue. Neither the oxygen saturated water nor argon nanobubbles produced a statistically significant change in HIF1α expression at the transcriptional level. In contrast, a reduction of 75% and 25% in the transcriptional and translational expression of HIF1α respectively (p

KW - Nanobubbles

KW - Oxygen

KW - Hypoxia

KW - HIF-1 alpha

U2 - 10.1371/journal.pone.0168088

DO - 10.1371/journal.pone.0168088

M3 - Article

VL - 11

SP - e0168088

JO - PLoS ONE

T2 - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 12

ER -

Owen J, McEwan C, Nesbitt H, Bovornchutichai P, Averre R, Borden M et al. Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles. PLoS ONE. 2016 Dec 30;11(12):e0168088. https://doi.org/10.1371/journal.pone.0168088